Peptide Compounding, From Source to Preparation

Peptides Are Defined by the System Behind Them.

The same amino acid sequence can be a very different product depending on how it's synthesized, sourced, and verified. At Strive, that system is the whole point. It reflects the same quality standards behind everything we do.

Not All Peptides Are Created Equal.

Peptides are having a moment. But every peptide reflects its process—and the difference may not show up on a label.

Every peptide is shaped by the system behind it: how it's synthesized, purified, sourced, formulated, and verified before it ever reaches a patient. That's the part most sourcing conversations skip.

At Strive, we built our process to control that variability at every step. From FDA-registered suppliers and Certificate of Analysis (COA)–backed active pharmaceutical ingredients (API) to ISO-classified cleanrooms and third-party release testing, every step is designed to support consistency between the labeled strength and the finished preparation.

This is how we approach peptide preparations: built for quality control from the ground up.

The Strive Standard

  • Sourced & Verified

    FDA-registered suppliers, full traceability, and COA-backed identity and purity on every API.

  • Purity, Understood

    Impurity profiles are reviewed, not ignored.

  • Dosing Built on Active Content

    Formulated from corrected active peptide content, not raw weight.

  • Endotoxin Tested, Every Sterile Batch

    Finished sterile preparations are tested before release.

  • Sterility by Design

    ISO-classified cleanrooms, validated aseptic technique, consistent monitoring.

  • Stability Backed by Data

    Stability in accordance with USP <797>.

  • Formulation with Intent

    Peptide-specific formulation variables carefully evaluated to support consistency across batches.

  • Independently Verified

    Third-party testing evaluates sterility and endotoxin levels before any sterile batch is released.

Strive Peptides

Compounded Individually, Pursuant to a Valid Prescription

More to come as FDA allows.

  • Injection & LPT

    BPC-157, coming soon

  • Injection

    MOTS-c, coming soon

  • Injection

    TB-500, coming soon

  • Injection

    Epitalon, coming soon

  • Oral Capsule

    KPV, coming soon

  • Nasal Spray

    Semax, coming soon

“Quality starts with the system behind the peptide. Ours is designed to reduce uncertainty through defined processes, controlled preparation, and verified quality.”

Compounded medications are specially prepared for identified individual patient needs based on a valid prescription from a prescribing healthcare practitioner and, as such, are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy. Individual outcomes may vary. Compounded drugs are intended for patients whose prescriber has determined their medical needs are not met by an available FDA-approved drug. These statements have not been evaluated by the FDA.

This information is intended for informational purposes only and does not constitute medical advice. Strive does not compound peptides for patient use without FDA regulatory authorization or enforcement discretion to do so. Any concentrations and dosing listed reflect Strive's development efforts and development work is ongoing. Production is entirely contingent on the FDA's regulatory posture and formal guidance. Strive will follow the FDA's lead.